We are conducting system maintenance, which may temporarily affect some services and our ability to answer phone calls. For urgent queries, please contact us via email using the addresses on our contact page. We appreciate your patience and are working to restore full services promptly. Thank you for your cooperation!
0
Signin
countryflagUS

18889881171

MSFT 416.99 -0.2798% AAPL 236.12 0.4766% NVDA 141.89 2.8188% GOOGL 163.9 0.2937% GOOG 165.62 0.3453% AMZN 188.49 -0.2646% META 572.8 -0.6366% AVGO 179.26 -0.3502% TSLA 217.715 -1.3525% TSM 201.3996 0.3086% LLY 907.515 -1.1389% V 287.48 -1.0804% JPM 223.49 -0.8342% UNH 572.61 0.5267% NVO 117.1969 -0.7563% WMT 81.0075 -0.372% LVMUY 132.13 -2.3429% XOM 120.405 0.3291% LVMHF 664.5 -1.9483% MA 515.685 -0.1269%

Voyageur Pharmaceuticals Ltd

Healthcare US VYYRF

0.045USD
-0.025(35.71%)

Last update at 2024-10-21T18:07:00Z

Day Range

0.040.04
LowHigh

52 Week Range

0.030.10
LowHigh

Fundamentals

  • Previous Close 0.07
  • Market Cap6.51M
  • Volume10000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.46306M
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-0.02

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Type yearly yearly yearly yearly yearly
Date 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Income before tax -1.75389M -2.05147M -1.13942M -0.55229M -0.55586M
Minority interest - - - - 0.00000M
Net income -1.75389M -2.05147M -1.13942M -0.55229M -0.55586M
Selling general administrative 1.22M 1.55M 1.00M 0.55M 0.87M
Selling and marketing expenses - - - - -
Gross profit - - - - 0.00000M
Reconciled depreciation 0.00921M 0.00225M 0.00148M 0.00212M -
Ebit - -1.97426M -1.13817M -0.53259M -0.84576M
Ebitda -1.74272M -2.04922M -0.99956M -0.55277M -0.86603M
Depreciation and amortization - - - - -
Non operating income net other - - - - 0.00000M
Operating income -1.75192M -2.05147M -1.00104M -0.55489M -0.86603M
Other operating expenses - - - - 0.00000M
Interest expense - 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense - - - - 0.00000M
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 1.75M 2.05M 1.00M 0.55M 0.87M
Cost of revenue - - - - 0.00000M
Total other income expense net -0.00197M - -0.13838M 0.00260M 0.31M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -1.75389M -2.05147M -1.13942M -0.55229M -0.55586M
Net income applicable to common shares - -2.05147M -1.13942M -0.55229M -0.55586M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Type yearly yearly yearly yearly yearly
Date 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Total assets 2.10M 2.57M 1.28M 1.61M 1.27M
Intangible assets - - - - 0.00000M
Earning assets - - - - -
Other current assets - - - - 0.00000M
Total liab 0.63M 0.66M 0.97M 0.85M 0.75M
Total stockholder equity 1.46M 1.91M 0.31M 0.75M 0.52M
Deferred long term liab - - - - 0.00000M
Other current liab - 0.05M 0.11M 0.05M 0.07M
Common stock - 6.27M 3.44M 3.04M 2.33M
Capital stock 7.55M 6.27M 3.44M 3.04M 2.33M
Retained earnings -7.72833M -5.97443M -3.92241M -2.78299M -2.23069M
Other liab - 0.01M 0.01M 0.01M 0.01M
Good will - - - - 0.00000M
Other assets - 0.01M 0.01M 0.01M 0.01M
Cash 0.03M 0.81M 0.00297M 0.08M 0.15M
Cash and equivalents - - - - -
Total current liabilities 0.59M 0.62M 0.91M 0.81M 0.57M
Current deferred revenue - - - - -
Net debt - - 0.24M 0.03M -
Short term debt - - - - 0.00000M
Short long term debt - - 0.21M 0.11M 0.00000M
Short long term debt total - - - - -
Other stockholder equity - - - - 0.00000M
Property plant equipment - 1.67M 1.24M 1.20M 1.02M
Total current assets 0.16M 0.89M 0.03M 0.40M 0.23M
Long term investments - - - - 0.00000M
Net tangible assets - 1.91M 0.31M 0.75M 0.52M
Short term investments - - - - 0.00000M
Net receivables 0.02M 0.04M 0.01M 0.10M 0.08M
Long term debt 0.03M 0.03M 0.03M - 0.14M
Inventory 0.01M 0.00971M 0.00988M 0.01M 0.00000M
Accounts payable 0.59M 0.55M 0.57M 0.47M 0.49M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income - - - - 0.00000M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other 0.01M 0.01M 0.01M 0.01M 0.01M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 1.94M 1.68M 1.25M 1.21M 1.04M
Capital lease obligations 0.00000M 0.02M 0.03M 0.03M 0.04M
Long term debt total - - - - 0.00000M
Breakdown 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Type yearly yearly yearly yearly yearly
Date 2022-11-30 2021-11-30 2020-11-30 2019-11-30 2018-11-30
Investments -0.27415M -0.43208M -0.15179M -0.16962M -0.22405M
Change to liabilities - -0.08188M 0.17M 0.15M 0.02M
Total cashflows from investing activities - -0.43208M -0.15179M -0.16962M -0.22405M
Net borrowings - -0.01885M 0.22M 0.02M 0.03M
Total cash from financing activities 1.21M 2.90M 0.35M 0.74M 0.84M
Change to operating activities - -0.26095M 0.27M -0.22703M 0.06M
Net income -1.75389M -2.05147M -1.13942M -0.55229M -0.55586M
Change in cash -0.78141M 0.81M -0.07265M -0.07130M 0.13M
Begin period cash flow 0.81M 0.00297M 0.08M 0.15M 0.02M
End period cash flow 0.03M 0.81M 0.00297M 0.08M 0.15M
Total cash from operating activities -1.71875M -1.65429M -0.27219M -0.63781M -0.49045M
Issuance of capital stock 1.16M 2.31M 0.15M 0.79M 0.91M
Depreciation 0.00921M 0.00225M 0.15M 0.00212M 0.00212M
Other cashflows from investing activities - 0.00000M 0.01M 0.00575M 0.10M
Dividends paid - - - - 0.00000M
Change to inventory -0.00061M 0.00017M 0.00023M -0.01011M -0.01011M
Change to account receivables 0.02M -0.02888M 0.00150M 0.00150M 0.00135M
Sale purchase of stock - - - - 0.00000M
Other cashflows from financing activities - -0.17597M -0.02702M -0.07951M -0.09721M
Change to netincome - 0.74M 0.28M 0.00271M -0.01511M
Capital expenditures 0.00000M 0.43M 0.16M 0.18M 0.33M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital -0.24372M -0.34266M 0.44M -0.09035M 0.08M
Stock based compensation 0.21M 0.74M 0.28M 0.00532M -
Other non cash items 0.06M -0.00000M -0.00373M - -
Free cash flow -1.71875M -1.65429M -0.27219M -0.63964M -0.49045M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
VYYRF
Voyageur Pharmaceuticals Ltd		 -0.025 35.71% 0.04 - - - 3.90 -2.5131
ZTS
Zoetis Inc		 -3.43 1.77% 189.85 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.74 2.07% 35.00 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 177.52 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.16 1.12% 14.17 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.

Voyageur Pharmaceuticals Ltd

339?50th Avenue SE, Calgary, AB, Canada, T2G 2B3

Key Executives

Name Title Year Born
Mr. Brent Willis Bsc.Eng Pres, CEO & Director 1971
Mr. Bradley Craig Willis P.Eng. Founder, COO & Director 1971
Mr. Albert Deslauriers Chief Financial Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.